1 min read

ID: 910059

Short Link: https://gregory-ms.com/articles/910059/

Discovery Date: 15 September 2022, 11:15:13 UTC

Published Date: 2022-09-15 10:00:00

Source: PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/36105617/

Manual Selection: true

Machine Learning Gaussian Naive Bayes Model: false

Abstract

CONCLUSION: Nano-rhMBP-RTX treated group ameliorated the adverse effects induced in the EAE model. The effectiveness of this formulation was demonstrated by the normalization of EAE-induced behavioral changes and aberrant levels of specific biochemical markers as well as reduced damage of hippocampal tissues and retaining higher levels of myelination.

Noun Phrases in Title

  • Nanoformulated Recombinant Human Myelin Basic Protein
  • Rituximab Modulate Neuronal Perturbations
  • Experimental Autoimmune Encephalomyelitis
  • Mice
This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.